← Open Payments lookup

KIMBERLY LOVETT: Open Payments

NPI 1720006125 · WORCESTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,793 in 155 payments from 12 companies in 2025. Trend: 2023 $241 · 2024 $1,714 · 2025 $2,793

Food & beverage: $2,650Education: $143
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)20$491
E.R. Squibb & Sons, L.L.C.11$366
ABBVIE INC.24$343
Otsuka America Pharmaceutical, Inc.17$334
Vanda Pharmaceuticals Inc.21$302
Teva Pharmaceuticals USA, Inc.11$264
Neurocrine BioSciences, Inc.32$212
Lundbeck LLC5$138
Alkermes, Inc.5$124
Supernus Pharmaceuticals, Inc.6$123

Products named: CAPLYTA, REXULTI, COBENFY, VRAYLAR, FANAPT, INGREZZA, AUSTEDO XR, Qelbree.

Industry payments across MA — which companies pay providers there.